Clinical Trials Insight: 700050589
Phase of Trial: Phase I
Latest Information Update: 17 Feb 2010
At a glance
- Drugs APD 405 (Primary)
- Indications Nausea and vomiting
- Focus Adverse reactions
- Sponsors Acacia Pharma
- 17 Feb 2010 Status changed from planning to completed.
- 03 Nov 2009 New trial record.